New pill aims to slow vision loss from dry macular degeneration
NCT ID NCT07606365
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an oral drug called STL303 for geographic atrophy, a form of dry age-related macular degeneration that causes a blind spot in central vision. About 300 adults aged 60 and older will receive either STL303 or a placebo pill for up to 2 years. The goal is to see if the drug safely slows the loss of cells in the retina and preserves eyesight.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- STL303 (oral drug)
- What this could lead to
- If it works, this could slow vision loss from geographic atrophy, helping people keep their central eyesight longer.
- What could go wrong
- This is an early Phase 2 trial with only 300 people. The drug may not slow vision loss or could cause side effects. Success is not guaranteed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GEOGRAPHIC ATROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Adelaide Eye and Retina Centre
Adelaide, South Australia, 5000, Australia
-
Associated Vitreoretinal and Uveitis Consultants
Carmel, Indiana, 46032, United States
-
Augenarzte Bern Zentrum Marktgasse
Bern, 3011, Switzerland
-
Axon Clinical s.r.o.
Prague, Prague, 150 00, Czechia
-
Berner Augenklinik
Bern, 3007, Switzerland
-
Buenos Aires Macula S.A
Buenos Aires, Buenos Aires, 1061, Argentina
-
California Retina Consultants
Bakersfield, California, 93309, United States
-
Centro Medico Viamonte SRL
Buenos Aires, Buenos Aires, C1120AAC, Argentina
-
Centro Oftalmologico Dr. Charles S.A.
Buenos Aires, Ciudad Autonoma Buenos Aires, C1121ABB, Argentina
-
Centro Privado de Ojos
Ciudad Autonoma Buenos Aires, Ciudad Autonoma Buenos Aires, C1033AAW, Argentina
-
Centro de Ojos Quilmes
Quilmes, Buenos Aires, 1878, Argentina
-
Centro de la Vision
Salta, Salta Province, 4400, Argentina
-
Centrovision Mendoza SA
Mendoza, Mendoza Province, 5500, Argentina
-
Centrum Diagnostyki i Mikrochirurgii Oka LENS
Olsztyn, 10-424, Poland
-
Centrum Medyczne
Wałbrzych, 58304, Poland
-
Centrum Medyczne Dietla 19
Krakow, 31-070, Poland
-
Centrum Zdrowia MDM
Warsaw, 00-189, Poland
-
Cerulea Pty Ltd
East Melbourne, Victoria, 3002, Australia
-
Clinical Medical Research Sp. z o.o.
Katowice, 40-156, Poland
-
Cumberland Valley Retina Consultants,P.C.
Hagerstown, Maryland, 21740, United States
-
Ente Ospedaliero Cantonale
Bellinzona, 6500, Switzerland
-
Erie Retina Research
Erie, Pennsylvania, 16507, United States
-
Eye Clinic of Wisconsin
Wausau, Wisconsin, 54403, United States
-
Fakultni nemocnice Kralovske Vinohrady
Prague, Prague, 100 34, Czechia
-
Florida Retina Institute
Wildwood, Florida, 34785, United States
-
Grupo Laser Visión - Rosario Eximer Laser Visión
Rosario, Santa Fe Province, 2000, Argentina
-
Hospital Britanico de Buenos Aires
Buenos Aires, Ciudad Autonoma Buenos Aires, 1008, Argentina
-
IMOC Instituto de Microcirugia Ocular Cordoba
Córdoba, Córdoba Province, X5000, Argentina
-
Instituoto Oftalmologico de Buenos Aires S.A.
Buenos Aires, Ciudad Autonoma Buenos Aires, C1056, Argentina
-
Kaiser Permanente - Oakland
Oakland, California, 94612, United States
-
Long Island and Queens Vitreoretinal Consultants of NY, P.C.
Hauppauge, New York, 11788, United States
-
Mid Atlantic Retina Specialists
Hagerstown, Maryland, 21740, United States
-
Northeast Wisconsin Retina Associates
Appleton, Wisconsin, 54914, United States
-
OFTEX, s.r.o.
Pardubice, Prague, 530 02, Czechia
-
Ophthalmic Consultants of Boston
Waltham, Massachusetts, 02451, United States
-
Poznanskie Centrum Wzroku sp z o o
Poznan, 60-538, Poland
-
Prywatna Klinika Okulistyczna OFTALMIKA
Bydgoszcz, 85-631, Poland
-
Queensland Eye Institute
South Brisbane, Queensland, 4101, Australia
-
Retina Consultants of Texas
Bellaire, Texas, 77401, United States
-
Retina Consultants of Texas
Schertz, Texas, 78154, United States
-
Retina Group of New England, PC
Waterford, Connecticut, 06385, United States
-
Retina Specialists of Colorado
Aurora, Colorado, 80012, United States
-
Retina Vitreous Associates of Florida
St. Petersburg, Florida, 33711, United States
-
Retina-Vitreous Associates Medical Group
Beverly Hills, California, 90211, United States
-
Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
-
Royal Victoria Infirmary
Newcastle upon Tyne, Tyne & Wear, NE1 4LP, United Kingdom
-
Southampton General Hospital
Southampton, Hampshire, SO16 6YD, United Kingdom
-
Specjalistyczna Praktyka Lekarska Prof. Edward Wylęgała
Katowice, 40-594, Poland
-
Specjalistyczny Osrodek Okulistyczny Oculomedica
Bydgoszcz, 00-189, Poland
-
Stadtspital Triemli
Zurich, 8063, Switzerland
-
Star Vision Research
Burleson, Texas, 76028, United States
-
Swiss Visio Montchoisi
Lausanne, 1006, Switzerland
-
Sydney Eye Hospital
Sydney, New South Wales, 2000, Australia
-
Sydney West Retina
Westmead, New South Wales, 2145, Australia
-
Szpital Swietego Lukasza S. A.
Bielsko-Biala, 43-309, Poland
-
Tennessee Retina, PC
Nashville, Tennessee, 37203, United States
-
The Retina Clinic London
London, Greater London, W1G 7LB, United Kingdom
-
University Hospitals of Leicester NHS Trust
Leicester, Leicestershire, LE5 4PW, United Kingdom
-
University Retina and Macula Associates, P.C.
Lemont, Illinois, 60439, United States
-
Vista Augenklinik Binningen
Binningen, 4102, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New eye imaging could reveal hidden clues to vision loss
- A new eye camera may spot stressed cells before vision loss begins
- Gene therapy injection aims to halt blinding eye disease
- Eye imaging showdown: which device measures macular damage best?
- Bionic eye implant aims to bring back sight in advanced macular degeneration
- New cell therapy aims to slow vision loss in retinal disease